ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,884, issued on Jan. 20, was assigned to GE Healthcare Ltd. (Buckinghamshire, Great Britain).

"Use of cyclodextrins as a radiostabilizer" was invented by Kristine Opsvik Wikene (Nydalen, Norway), Imtiaz Ahmed Khan (Buckinghamshire, Great Britain) and Graeme McRobbie (Buckinghamshire, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a radiopharmaceutical composition comprising the following four components: (i) a radio-labelled compound; (ii) ethanol; (iii) a stabilizer of the radio-labelled compound; and (iv) a cyclodextrin.The present invention also provides a radiopharmaceutical composition comprising: (i)...